mifepristone has been researched along with Hemorrhage in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (5.26) | 18.7374 |
| 1990's | 4 (21.05) | 18.2507 |
| 2000's | 8 (42.11) | 29.6817 |
| 2010's | 6 (31.58) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Atrio, J; Barnhart, KT; Creinin, MD; Ratcliffe, SJ; Schreiber, CA; Sonalkar, S | 1 |
| Cleland, K; Smith, N | 1 |
| Brolin, L; Hedqvist, M; Larsson, M; Tydén, T | 1 |
| Li, L; Messina, JL; Thompson, LH; Zhao, L | 1 |
| Gissler, M; Heikinheimo, O; Hemminki, E; Mentula, M; Niinimäki, M; Suhonen, S | 1 |
| de la Peña, A; Espinoza, J; Perusquía, M | 1 |
| Bussieres, L; Camus, E; Fauconnier, A; Huchon, C; Machevin, E; Torre, A | 1 |
| Cooke, ID; Dockery, P; Li, TC; Rogers, AW | 1 |
| He, X; Liao, D; Tan, B; Xin, H | 1 |
| Haukkamaa, M; Heikinheimo, O; Suhonen, S; Tikka, M | 1 |
| Jochem, J | 1 |
| Harper, CC; Henderson, JT; Hwang, AC; Stewart, FH | 1 |
| Agarwal, S; Batra, A; Kumar, S; Mittal, S | 1 |
| Miech, RP | 1 |
| Fraser, IS; Kaitu'u-Lino, TJ; Morison, NB; Salamonsen, LA | 1 |
| Coyaji, K; Ellertson, C; Elul, B; Winikoff, B | 1 |
| Dunn, S; Guilbert, E; Jacot, F; Lugtig, L; Wiebe, E | 1 |
| Baird, DT; Cameron, IT; Michie, AF | 1 |
5 trial(s) available for mifepristone and Hemorrhage
| Article | Year |
|---|---|
Mifepristone Pretreatment for the Medical Management of Early Pregnancy Loss.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Spontaneous; Administration, Intravaginal; Administration, Oral; Adult; Drug Therapy, Combination; Embryo, Mammalian; Female; Fetal Death; Gestational Sac; Hemorrhage; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, First; Ultrasonography | 2018 |
Immediate versus delayed medical treatment for first-trimester miscarriage: a randomized trial.
Topics: Abortifacient Agents; Abortion, Spontaneous; Adult; Female; Hemorrhage; Humans; Infections; Mifepristone; Misoprostol; Pain; Pregnancy; Pregnancy Trimester, First; Treatment Outcome; Vacuum Curettage | 2012 |
Comparison or oral versus vaginal misoprostol & continued use of misoprostol after mifepristone for early medical abortion.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Administration, Intravaginal; Administration, Oral; Adult; Double-Blind Method; Female; Hemorrhage; Humans; Mifepristone; Misoprostol; Pregnancy; Time Factors | 2005 |
Comparison of abortions induced by methotrexate or mifepristone followed by misoprostol.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Adult; Female; Hemorrhage; Humans; Methotrexate; Mifepristone; Misoprostol; Pain; Pregnancy | 2002 |
Therapeutic abortion in early pregnancy with antiprogestogen RU486 alone or in combination with prostaglandin analogue (gemeprost).
Topics: Abortifacient Agents; Abortifacient Agents, Steroidal; Abortion, Therapeutic; Administration, Intravaginal; Alprostadil; Drug Combinations; Estrenes; Female; Hemorrhage; Humans; Mifepristone; Nausea; Pregnancy; Pregnancy Trimester, First | 1986 |
14 other study(ies) available for mifepristone and Hemorrhage
| Article | Year |
|---|---|
Aligning mifepristone regulation with evidence: driving policy change using 15 years of excellent safety data.
Topics: Abdominal Pain; Abortifacient Agents, Steroidal; Abortion, Induced; Evidence-Based Medicine; Female; Fever; Hemorrhage; Humans; Mifepristone; Pregnancy; United States; United States Food and Drug Administration | 2015 |
Women's experiences of having an early medical abortion at home.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Access to Information; Adolescent; Adult; Cross-Sectional Studies; Female; Gravidity; Hemorrhage; Humans; Middle Aged; Mifepristone; Pain; Patient Satisfaction; Pregnancy; Surveys and Questionnaires; Young Adult | 2016 |
Tissue-specific difference in the molecular mechanisms for the development of acute insulin resistance after injury.
Topics: Acute Disease; Animals; Corticosterone; Fatty Acids, Nonesterified; Hemorrhage; Hormone Antagonists; Insulin; Insulin Resistance; Liver; Male; Metyrapone; Mifepristone; Muscle, Skeletal; Phosphoserine; Rats; Rats, Sprague-Dawley; Signal Transduction; Wounds and Injuries | 2009 |
Comparison of rates of adverse events in adolescent and adult women undergoing medical abortion: population register based study.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Incomplete; Abortion, Induced; Adolescent; Adult; Age Distribution; Chlamydia Infections; Female; Finland; Hemorrhage; Humans; Incidence; Mifepristone; Misoprostol; Pregnancy; Pregnancy Complications, Cardiovascular; Registries; Risk Factors; Young Adult | 2011 |
Mifepristone (RU 486) induces vasodilation and inhibits platelet aggregation: nongenomic and genomic action to cause hemorrhage.
Topics: Adenosine Diphosphate; Animals; Aorta, Thoracic; Endothelium, Vascular; Female; Gene Expression Regulation; Hemorrhage; Humans; In Vitro Techniques; Male; Mifepristone; Platelet Aggregation; Potassium Chloride; Pregnancy; Rats; Rats, Wistar; Serotonin; Umbilical Arteries; Vasodilation | 2011 |
Histological and clinical features of menstruation induced by the antiprogestin mifepristone (RU486) compared to menstruation occurring spontaneously.
Topics: Biology; Cell Biology; Clinical Laboratory Techniques; Developed Countries; Diagnosis; Disease; Endocrine System; Endometrium; England; Europe; Genitalia; Genitalia, Female; Hemorrhage; Histology; Hormone Antagonists; Hormones; Human Experimentation; Menstrual Cycle; Menstruation; Mifepristone; Physiology; Reproduction; Research; Signs and Symptoms; United Kingdom; Urogenital System; Uterus | 1990 |
Comparing the effectiveness of different doses of mifepristone.
Topics: Biology; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Postcoital; Disease; Endocrine System; Family Planning Services; Hemorrhage; Hormone Antagonists; Hormones; Menstruation Disturbances; Mifepristone; Physiology; Research; Signs and Symptoms | 1999 |
Studies on relationship between serum nitric oxide and plasma cyclic guanosine monophosphate and prolonged bleeding after medical abortion as well as prophylaxis and treatment of bleeding with traditional Chinese medicine.
Topics: Abortion, Induced; Asia; Asia, Eastern; Biology; Chemical Phenomena; Chemistry; China; Developing Countries; Disease; Endocrine System; Enzymes; Family Planning Services; Hemorrhage; Hormone Antagonists; Hormones; Inorganic Chemicals; Mifepristone; Physiology; Research; Signs and Symptoms; Therapeutics | 1999 |
The learning curve is rapid in medical termination of pregnancy--first-year results from the Helsinki area.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Adolescent; Adult; Analgesia; Female; Finland; Hemorrhage; Humans; Mifepristone; Misoprostol; Patient Satisfaction; Pregnancy; Pregnancy Trimester, First; Surveys and Questionnaires | 2003 |
Involvement of proopiomenalocortin-derived peptides in endogenous central histamine-induced reversal of critical haemorrhagic hypotension in rats.
Topics: Adrenocorticotropic Hormone; alpha-MSH; Animals; Brain Chemistry; Disease Models, Animal; Heart Rate; Hemorrhage; Hindlimb; Histamine; Hypotension; Injections, Intraventricular; Injections, Subcutaneous; Male; Mifepristone; Peptides, Cyclic; Pro-Opiomelanocortin; Pyrimethamine; Rats; Rats, Wistar; Receptor, Melanocortin, Type 4; Regional Blood Flow; Renal Circulation; Shock, Hemorrhagic; Splanchnic Circulation; Time Factors | 2004 |
Safety of mifepristone abortions in clinical use.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Confidence Intervals; Female; Hemorrhage; Humans; Mifepristone; Safety | 2005 |
Pathopharmacology of excessive hemorrhage in mifepristone abortions.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Animals; Female; Hemorrhage; Hemostasis; Humans; Mifepristone; Nitric Oxide; Pregnancy; Receptors, Glucocorticoid; Uterus | 2007 |
Stimulation of epithelial repair is a likely mechanism for the action of mifepristone in reducing duration of bleeding in users of progestogen-only contraceptives.
Topics: Animals; Contraceptives, Oral, Synthetic; Endometrium; Estrogen Receptor alpha; Female; Hemorrhage; Humans; Immunohistochemistry; Injections, Subcutaneous; Keratins; Mice; Mice, Inbred C57BL; Mifepristone; Models, Animal; Progestins; Pseudopregnancy; Receptors, Progesterone; Stimulation, Chemical; Wound Healing | 2008 |
Side effects of mifepristone-misoprostol abortion versus surgical abortion. Data from a trial in China, Cuba, and India.
Topics: Abortifacient Agents; Abortion, Induced; Abortion, Legal; Adult; China; Cuba; Drug Therapy, Combination; Female; Hemorrhage; Humans; India; Mifepristone; Misoprostol; Pain; Pregnancy | 1999 |